Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

VASICAN TABLET 8 mg

Approval Number

SIN02528P

Drug Name

VASICAN TABLET 8 mg

Product Name

VASICAN TABLET 8 mg

Approval Date

April 18, 1989

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

R05CB02

ATC Item Name

bromhexine

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

PT. ACTAVIS INDONESIA

Active Ingredients

Ingredient Name

BROMHEXINE HCl

Strength

8 mg

Drug MonographBromhexine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

VASICAN TABLET 8 mg - HSA Approval | MedPath